참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Chloramphenicol | HCID 5959 | — |
| 반응물 | (+-)-Mevalonolactone | HCID 10428 | — |
| 반응물 | Decane | HCID 15600 | — |
| 반응물 | isopropyl beta-D-thiogalactopyranoside | HCID 656894 | — |
| 반응물 | (R)-mevalonate | HCID 5288798 | — |
| 용매 | Sodium Hydroxide | HCID 14798 | — |
| 생성물 | beta-Santalene | HCID 10889018 | — |
반응 단계
BL21 Star™ (DE3) E. coli cells (Invitrogen) were co-transformed with the plasmids pACYCDuet-4506 and Ct94-pETDuet and transformed cells were selected on carbenicillin (50 μg/ml) chloramphenicol (34 μg/ml) LB-agarose plates. Single colonies were used to inoculate 5 mL LB medium with 50 μg/ml carbenicilin and 34 μg/ml chloramphenicol. The culture was incubated overnight at 37° C. The next day 2 mL of TB medium supplemented with the same antibiotics were inoculated with 0.2 mL of the overnight culture. After 6 hours incubation at 37° C., the culture was cooled down to 28° C. and 1 mM IPTG, 2 mg/mL mevalonate (prepared by dissolving mevalonolactone (Sigma) in 0.5N NaOH at a concentration of 1 g/mL and incubating the solution for 30 minutes at 37° C.) and 0.2 mL decane were added to each tube. The cultures were incubated for 48 hours at 28° C. The cultures were then extracted twice with 2 volumes of ethyl acetate, the organic phase was concentrated to 500 μL and analyzed by GC-MS as described above in Example 3. In these conditions sesquiterpene production above 200 mg/L was routinely achieved. Beta-santalene was produced.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08877461B2 |
|---|
| 출처 데이터셋 | uspto-grants-2014_11 |
|---|
| ORD ID | ord-4ca4f30d8c5e4b09a6e3d9311fd72b30 |
|---|
| 출처 메모 | uspto-grants-2014_11 |
|---|